Though therapeutic treatments are generally trialled, approved and introduced based on the assumption of correct usage, actual patient adherence has been shown across a range of situations to be less than 50%,
resulting in undertreated conditions, increased emergency admissions, and reduced public health outcomes. In the following editorial, David Griffin, Senior Consultant at 42 Technology answers the question: can technology alone tackle the issue of medicine adherence?
https://international-pharma.com/wp-content/uploads/2015/04/12.-Can-Technology-Alone-Tackle.pdf